Literature DB >> 3004898

Corticotropin-releasing factor binding to the anterior pituitary receptor is modulated by divalent cations and guanyl nucleotides.

M H Perrin, Y Haas, J E Rivier, W W Vale.   

Abstract

The binding of ovine CRF to bovine anterior pituitary membranes was characterized with the radioligand [Nle21, m-125I Tyr32]ovine CRF. The specific binding of CRF was increased by millimolar concentrations of the divalent cations Mg2+, Ca2+, and Mn2+, but was unaffected by the monovalent cations Na+, Ki+, and Li+. The increase in specific binding was not caused by a change in the affinity, but resulted from an apparent increased number of high affinity binding sites. In the presence of 10 mM Mg2+, CRF binding was saturable, specific, and of high affinity. At room temperature, under optimum conditions, binding reached equilibrium within 70 min, remained stable for at least 4 h, was reversible by excess unlabeled peptide, and was characterized by a Kd of 1.3 nM (0.74-2.4) and a total number of sites, R degree, of 90 fmol/mg protein (55-145). The affinity for the bovine membranes was the same as that for rat anterior pituitary membrane homogenates, and the concentrations of sites were similar. The relative binding affinities for the CRF receptor of selected agonists and antagonists in the bovine and rat systems were similar, and both showed good correlation with the relative in vitro potencies at stimulating or antagonizing, respectively, ACTH release from cultured rat anterior pituitary cells. The nonhydrolyzable GTP analog 5'-guanylylimidodiphosphate [Gpp(NH)p], caused a dose-dependent inhibition of bound radioligand, with an EC50 of about 0.5 microM. In the presence of 1 microM Gpp(NH)p, the number of high affinity CRF-binding sites was reduced, but the affinity was unchanged. In the presence of 5 microM Gpp(NH)p, there was no detectable high affinity binding, and the rate of dissociation of previously bound radioligand was increased. The other guanyl nucleotides, GTP and GDP, inhibited binding but to a lesser extent, whereas GMP and (Bu)2cGMP were ineffective. The inhibition was specific for guanyl nucleotides. In view of the established effects of guanyl nucleotides and divalent cations on adenylate cyclase-linked receptors, these data support the involvement of the adenylate cyclase system in the mechanism of action of CRF on the anterior pituitary.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3004898     DOI: 10.1210/endo-118-3-1171

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

Review 1.  Minireview: CRF and Wylie Vale: a story of 41 amino acids and a Texan with grit.

Authors:  Tracy L Bale; Alon Chen
Journal:  Endocrinology       Date:  2012-04-04       Impact factor: 4.736

2.  Expression cloning of a human corticotropin-releasing-factor receptor.

Authors:  R Chen; K A Lewis; M H Perrin; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

3.  Polymer-based cell-free expression of ligand-binding family B G-protein coupled receptors without detergents.

Authors:  Christian Klammt; Marilyn H Perrin; Innokentiy Maslennikov; Ludovic Renault; Martin Krupa; Witek Kwiatkowski; Henning Stahlberg; Wylie Vale; Senyon Choe
Journal:  Protein Sci       Date:  2011-05-03       Impact factor: 6.725

4.  In vivo labeling with1251-CRH of human ACTH-producing pituitary adenomas heterotransplanted to nude mice.

Authors:  Uirich J Knappe; Dieter K Lüdecke; Maximilian J A Puchner; Wolfgang Saeger; Hans-D Herrmann
Journal:  Endocr Pathol       Date:  1991-12       Impact factor: 3.943

5.  Corticotropin-releasing hormone deficiency unmasks the proinflammatory effect of epinephrine.

Authors:  K P Karalis; E Kontopoulos; L J Muglia; J A Majzoub
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

6.  Characterization of a Pachymedusa dacnicolor-Sauvagine analog as a new high-affinity radioligand for corticotropin-releasing factor receptor studies.

Authors:  Marilyn H Perrin; Laura A Tan; Joan M Vaughan; Kathy A Lewis; Cynthia J Donaldson; Charleen Miller; Judit Erchegyi; Jean E Rivier; Paul E Sawchenko
Journal:  J Pharmacol Exp Ther       Date:  2015-03-03       Impact factor: 4.030

Review 7.  The role of intracellular messengers in adrenocorticotropin secretion in vitro.

Authors:  M S King; A J Baertschi
Journal:  Experientia       Date:  1990-01-15

8.  Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart.

Authors:  M Perrin; C Donaldson; R Chen; A Blount; T Berggren; L Bilezikjian; P Sawchenko; W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  Immunoreactive corticotropin-releasing hormone and its binding sites in the rat ovary.

Authors:  G Mastorakos; E L Webster; T C Friedman; G P Chrousos
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

10.  Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary.

Authors:  E Potter; S Sutton; C Donaldson; R Chen; M Perrin; K Lewis; P E Sawchenko; W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.